Lexicon Pharmaceuticals Inc (LXRX.OQ)
22 Oct 2018
Latest Key Developments (Source: Significant Developments)
Nov 8 (Reuters) - Lexicon Pharmaceuticals Inc
PARIS Sanofi sees a more diversified pipeline driving a return to growth at its diabetes unit in the coming years and will consider acquisitions and partnerships to help boost performance, a company executive said on Tuesday.